1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2. Executive Summary
2.1. Market Snapshot: Global Respiratory Syncytial Virus (RSV) Diagnostics Market
2.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Technology
2.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By End Users
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value, 2016-2028, (US$ Mn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Major Industry Challenges
3.2.3. Key Growth Pockets
3.3. Attractive Investment Proposition,2021
3.3.1. Technology
3.3.2. End Users
3.3.3. Geography
3.4. Porter’s Five Forces Analysis
3.4.1. Threat of New Entrants
3.4.2. Bargaining Power of Buyers/Consumers
3.4.3. Bargaining Power of Suppliers
3.4.4. Threat of Substitute Types
3.4.5. Intensity of Competitive Rivalry
3.5. Value Chain Analysis
4. Market Positioning of Key Players, 2021
4.1. Company market share of key players, 2021
4.2. Competitive Benchmarking
4.3. Geographical Presence Analysis
4.4. Major Strategies Adopted by Key Players
4.4.1. Key Strategies Analysis
4.4.2. Mergers and Acquisitions
4.4.3. Partnerships
4.4.4. Product Launch
4.4.5. Geographical Expansion
4.4.6. Others
5. COVID 19 Impact Analysis
5.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Pre Vs Post COVID 19, 2019 – 2028
5.2. Impact on Import & Export
5.3. Impact on Demand & Supply
6. Global
6.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
6.1.1. Overview
6.1.2. RSV Molecular Diagnostics
6.1.3. RSV Monoclonal Antibodies
6.1.4. Immunoassays
6.1.5. Differential Light Scattering
6.1.6. Artificial Intelligence
6.1.7. Liposomes
6.1.8. Flow Cytometry
6.1.9. Chromatography
6.1.10. Diagnostic Imaging
6.1.11. Gel Microdroplets
6.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
6.2.1. Overview
6.2.2. Hospitals
6.2.3. Nursing Homes
6.2.4. Commercial Laboratories
6.2.5. Public Health Laboratories
7. North America
7.1. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
7.1.1. U.S.
7.1.2. Canada
7.2. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
7.2.1. Overview
7.2.2. RSV Molecular Diagnostics
7.2.3. RSV Monoclonal Antibodies
7.2.4. Immunoassays
7.2.5. Differential Light Scattering
7.2.6. Artificial Intelligence
7.2.7. Liposomes
7.2.8. Flow Cytometry
7.2.9. Chromatography
7.2.10. Diagnostic Imaging
7.2.11. Gel Microdroplets
7.3. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
7.3.1. Overview
7.3.2. Hospitals
7.3.3. Nursing Homes
7.3.4. Commercial Laboratories
7.3.5. Public Health Laboratories
7.3.6. U.S.
7.4. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
7.4.1.1. U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
7.4.1.2. U.S. Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
7.4.1.3. U.S. Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
7.4.2. Canada
7.4.2.1. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
7.4.2.2. Canada Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
7.4.2.3. Canada Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8. Europe
8.1. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
8.1.1. UK
8.1.2. France
8.1.3. Germany
8.1.4. Italy
8.1.5. Spain
8.1.6. Rest of Europe
8.2. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
8.2.1. Overview
8.2.2. RSV Molecular Diagnostics
8.2.3. RSV Monoclonal Antibodies
8.2.4. Immunoassays
8.2.5. Differential Light Scattering
8.2.6. Artificial Intelligence
8.2.7. Liposomes
8.2.8. Flow Cytometry
8.2.9. Chromatography
8.2.10. Diagnostic Imaging
8.2.11. Gel Microdroplets
8.3. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
8.3.1. Overview
8.3.2. Hospitals
8.3.3. Nursing Homes
8.3.4. Commercial Laboratories
8.3.5. Public Health Laboratories
8.4. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
8.4.1. Germany
8.4.1.1. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.1.2. Germany Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.1.3. Germany Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.2. France
8.4.2.1. France Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.2.2. France Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.2.3. France Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.3. UK
8.4.3.1. UK Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.3.2. UK Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.3.3. UK Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.4. Italy
8.4.4.1. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.4.2. Italy Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.4.3. Italy Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.5. Spain
8.4.5.1. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.5.2. Spain Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.5.3. Spain Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.6. Rest of Europe
8.4.6.1. Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.6.2. Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.6.3. Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9. Asia Pacific
9.1. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
9.1.1. China
9.1.2. Japan
9.1.3. South Korea
9.1.4. India
9.1.5. South East Asia
9.1.6. Rest of Asia Pacific
9.2. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
9.2.1. Overview
9.2.2. RSV Molecular Diagnostics
9.2.3. RSV Monoclonal Antibodies
9.2.4. Immunoassays
9.2.5. Differential Light Scattering
9.2.6. Artificial Intelligence
9.2.7. Liposomes
9.2.8. Flow Cytometry
9.2.9. Chromatography
9.2.10. Diagnostic Imaging
9.2.11. Gel Microdroplets
9.3. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
9.3.1. Overview
9.3.2. Hospitals
9.3.3. Nursing Homes
9.3.4. Commercial Laboratories
9.3.5. Public Health Laboratories
9.4. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
9.4.1. China
9.4.1.1. China Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.1.2. China Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.1.3. China Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.2. Japan
9.4.2.1. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.2.2. Japan Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.2.3. Japan Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.3. India
9.4.3.1. India Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.3.2. India Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.3.3. India Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.4. South Korea
9.4.4.1. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.4.2. South Korea Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.4.3. South Korea Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.5. South-East Asia
9.4.5.1. South-East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.5.2. South-East Asia Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.5.3. South-East Asia Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.6. Rest of Asia Pacific
9.4.6.1. Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.6.2. Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.6.3. Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
10. Latin America
10.1. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
10.1.1. Brazil
10.1.2. Mexico
10.1.3. Rest of Latin America
10.2. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
10.2.1. Overview
10.2.2. RSV Molecular Diagnostics
10.2.3. RSV Monoclonal Antibodies
10.2.4. Immunoassays
10.2.5. Differential Light Scattering
10.2.6. Artificial Intelligence
10.2.7. Liposomes
10.2.8. Flow Cytometry
10.2.9. Chromatography
10.2.10. Diagnostic Imaging
10.2.11. Gel Microdroplets
10.3. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
10.3.1. Overview
10.3.2. Hospitals
10.3.3. Nursing Homes
10.3.4. Commercial Laboratories
10.3.5. Public Health Laboratories
10.4. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
10.4.1. Brazil
10.4.1.1. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.1.2. Brazil Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
10.4.1.3. Brazil Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
10.4.2. Mexico
10.4.2.1. Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.2.2. Mexico Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
10.4.2.3. Mexico Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
10.4.3. Rest of Latin America
10.4.3.1. Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.3.2. Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
10.4.3.3. Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
11. Middle East & Africa
11.1. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
11.1.1. GCC Countries
11.1.2. South Africa
11.1.3. Rest of Middle East & Africa
11.2. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
11.2.1. Overview
11.2.2. RSV Molecular Diagnostics
11.2.3. RSV Monoclonal Antibodies
11.2.4. Immunoassays
11.2.5. Differential Light Scattering
11.2.6. Artificial Intelligence
11.2.7. Liposomes
11.2.8. Flow Cytometry
11.2.9. Chromatography
11.2.10. Diagnostic Imaging
11.2.11. Gel Microdroplets
11.3. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
11.3.1. Overview
11.3.2. Hospitals
11.3.3. Nursing Homes
11.3.4. Commercial Laboratories
11.3.5. Public Health Laboratories
11.4. Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
11.4.1. GCC Countries
11.4.1.1. GCC Countries il Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.1.2. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
11.4.1.3. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
11.4.1.4. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By Deployment, 2016-2028 (US$ Bn)
11.4.1.5. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By Platform, 2016-2028 (US$ Bn)
11.4.1.6. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By End User, 2016-2028 (US$ Bn)
11.4.2. South Africa
11.4.2.1. South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.2.2. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
11.4.2.3. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
11.4.2.4. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Deployment, 2016-2028 (US$ Bn)
11.4.2.5. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Platform, 2016-2028 (US$ Bn)
11.4.2.6. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By End User, 2016-2028 (US$ Bn)
11.4.3. Rest of Middle East & Africa and Africa
11.4.3.1. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.3.2. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
11.4.3.3. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
11.4.3.4. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Deployment, 2016-2028 (US$ Bn)
11.4.3.5. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Platform, 2016-2028 (US$ Bn)
11.4.3.6. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By End User, 2016-2028 (US$ Bn)
12. Company Profiles
12.1. Abbott Laboratories
12.2. Becton
12.3. Dickinson and Company
12.4. BioMérieux SA
12.5. Bio-Rad Laboratories
12.6. Coris BioConcept
12.7. DiaSorin Molecular LLC (DiaSorin Inc)
12.8. F. Hoffmann-La Roche AG
12.9. Merck KgaA
12.10. Quest Diagnostics Incorporated
12.11. Quidel Corporation
12.12. Thermo Fisher Scientific
12.13. Others
List of Figures
FIG. 1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segmentation
FIG. 4 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2021 (US$ Mn)
FIG. 5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2021 (US$ Mn)
FIG. 6 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Geography, 2021 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Technology, 2021
FIG. 8 Attractive Investment Proposition, by End Users, 2021
FIG. 9 Attractive Investment Proposition, by Geography, 2021
FIG. 10 Global Market Positioning of Key Respiratory Syncytial Virus (RSV) Diagnostics Market Manufacturers, 2019
FIG. 11 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value Contribution, By Technology, 2021 & 2028 (Value %)
FIG. 12 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by RSV Molecular Diagnostics, Value, 2016-2028 (US$ Mn)
FIG. 13 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by RSV Monoclonal Antibodies, Value, 2016-2028 (US$ Mn)
FIG. 14 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Immunoassays, Value, 2016-2028 (US$ Mn)
FIG. 15 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Differential Light Scattering, Value, 2016-2028 (US$ Mn)
FIG. 16 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Artificial Intelligence, Value, 2016-2028 (US$ Mn)
FIG. 17 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Liposomes, Value, 2016-2028 (US$ Mn)
FIG. 18 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Flow Cytometry, Value, 2016-2028 (US$ Mn)
FIG. 19 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Chromatography, Value, 2016-2028 (US$ Mn)
FIG. 20 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Diagnostic Imaging, Value, 2016-2028 (US$ Mn)
FIG. 21 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Gel Microdroplets, Value, 2016-2028 (US$ Mn)
FIG. 22 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value Contribution, By End Users, 2021 & 2028 (Value %)
FIG. 23 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Hospitals, Value, 2016-2028 (US$ Mn)
FIG. 24 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Nursing Homes, Value, 2016-2028 (US$ Mn)
FIG. 25 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Commercial Laboratories, Value, 2016-2028 (US$ Mn)
FIG. 26 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Public Health Laboratories, Value, 2016-2028 (US$ Mn)
FIG. 27 U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 28 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 29 U.K. Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 30 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 31 France Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 32 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 33 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 34 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 35 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 36 China Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 37 India Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 38 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 39 Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 40 Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 41 Middle East & Africa & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 42 South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 43 GCC Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 44 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 45 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 46 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 47 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 48 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global Respiratory Syncytial Virus (RSV) Diagnostics Market
TABLE 2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Competitive Benchmarking, 2021
TABLE 3 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Key Strategies Analysis, 2021
TABLE 5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 6 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 7 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Geography, 2016-2028 (US$ Mn)
TABLE 8 North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 9 North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 10 North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Mn)
TABLE 11 US Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 12 US Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 13 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 14 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 15 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 16 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 17 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Mn)
TABLE 18 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 19 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 20 France Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 21 France Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 22 UK Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 23 UK Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 24 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 25 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 26 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 27 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 28 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 29 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$
TABLE 30 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Mn)
TABLE 31 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 32 China Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 33 China Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 34 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 35 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 36 India Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 37 India Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 38 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 39 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 40 South East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 41 Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 42 Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 43 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 44 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 45 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Mn)
TABLE 46 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 47 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 48 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 49 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 50 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 51 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 52 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 53 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 54 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Mn)
TABLE 55 GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 56 GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market, by Deployment, 2016-2028 (US$ Bn)
TABLE 57 GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market, by Platform, 2016-2028 (US$ Bn)
TABLE 58 GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 59 South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 60 South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 61 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 62 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)